Total Liabilities for Gilead Sciences (GILD)
According to Gilead Sciences's latest reported financial statements, the company's latest reported total liabilities is $36.41B USD. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and net assets for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
GILD
Currently viewingTotal LiabilitiesSwitch metric
Latest period
$36.41B
YoY change
-8.4%
5Y CAGR
-6.2%
Peak year (2020)
$50.19B
Latest annual
$36.41B
Total Liabilities history chart for Gilead Sciences (GILD) from 1990 to 2025
Total Liabilities history table for Gilead Sciences (GILD) from 1990 to 2025
| Fiscal year | Period ended | Reported | Total Liabilities | YoY |
|---|---|---|---|---|
| 2025 | $36.41B | -8.4% | ||
| 2024 | $39.75B | +0.9% | ||
| 2023 | $39.38B | -6.2% | ||
| 2022 | $41.96B | -10.5% | ||
| 2021 | $46.89B | -6.6% | ||
| 2020 | $50.19B | +28.8% | ||
| 2019 | $38.98B | -7.5% | ||
| 2018 | $42.14B | -15.3% | ||
| 2017 | $49.78B | +32.3% | ||
| 2016 | $37.61B | +15.4% | ||
| 2015 | $32.60B | +73.0% | ||
| 2014 | $18.84B | +73.9% | ||
| 2013 | $10.83B | -7.4% | ||
| 2012 | $11.70B | +12.1% | ||
| 2011 | $10.44B | +90.8% | ||
| 2010 | $5.47B | +71.3% | ||
| 2009 | $3.19B | +29.2% | ||
| 2008 | $2.47B | +10.6% | ||
| 2007 | $2.23B | +0.8% | ||
| 2006 | $2.22B | +200.2% | ||
| 2005 | $738.54M | +159.1% | ||
| 2004 | $285.09M | -48.3% | ||
| 2003 | $551.75M | -23.0% | ||
| 2002 | $716.84M | +109.4% | ||
| 2001 | $342.35M | +4.7% | ||
| 2000 | $326.98M | +134.4% | ||
| 1999 | $139.52M | -9.5% | ||
| 1998 | $154.10M | +342.8% | ||
| 1997 | $34.80M | +83.2% | ||
| 1996 | $19.00M | +25.0% | ||
| 1995 | $15.20M | -6.7% | ||
| 1994 | $16.30M | — | ||
| 1992 | $7.40M | +138.7% | ||
| 1991 | $3.10M | +34.8% | ||
| 1990 | $2.30M | — |
Total Liabilities values are taken from Gilead Sciences's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual total liabilities for Gilead Sciences (GILD) came in at $36.41B – declined 8.4% year-over-year.
Through 2020–2025 (5 years), Gilead Sciences total liabilities delivered a -6.2% annualised rate; with a net decline across the window.
2020 marks the peak total liabilities at $50.19B, with the historical low of $2.30M recorded in 1990.
Gilead Sciences (GILD) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $101.80B.
Gilead Sciences Total Liabilities by Year
Gilead Sciences Total Liabilities 2025: $36.41B
Gilead Sciences total liabilities in 2025 was $36.41B, declined 8.4% below 2024.
Gilead Sciences Total Liabilities 2024: $39.75B
Gilead Sciences total liabilities in 2024 was $39.75B, edged up 0.9% from 2023.
Gilead Sciences Total Liabilities 2023: $39.38B
Gilead Sciences total liabilities in 2023 was $39.38B, declined 6.2% below 2022.
Gilead Sciences Total Liabilities 2022: $41.96B
Gilead Sciences total liabilities in 2022 was $41.96B, declined 10.5% below 2021.
Gilead Sciences Total Liabilities 2021: $46.89B
Gilead Sciences total liabilities in 2021 was $46.89B.
See more financial history for Gilead Sciences (GILD).
Sector peers — Total Liabilities
Companies in the same sector as Gilead Sciences, ranked by their latest total liabilities.
| Company | Total Liabilities | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $348.86B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $207.88B | Healthcare |
| AbbVie Inc. (ABBV) | $137.19B | Healthcare |
| Johnson & Johnson (JNJ) | $117.67B | Healthcare |
| Eli Lilly and Company (LLY) | $85.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $84.20B | Healthcare |
| Amgen Inc. (AMGN) | $81.93B | Healthcare |
| AstraZeneca PLC (AZN) | $65.36B | Healthcare |
Frequently asked questions
What is Gilead Sciences's total liabilities?
- Latest reported total liabilities for Gilead Sciences (GILD) is $36.41B (period ending December 31, 2025).
How has Gilead Sciences total liabilities changed year-over-year?
- Gilead Sciences (GILD) total liabilities changed -8.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Gilead Sciences total liabilities?
- Gilead Sciences (GILD) total liabilities compound annual growth rate is -6.2% over the most recent 5 years available.
When did Gilead Sciences total liabilities hit its highest annual value?
- Gilead Sciences total liabilities reached its highest annual value of $50.19B in 2020.
What was Gilead Sciences total liabilities in 2024?
- Gilead Sciences (GILD) total liabilities in 2024 was $39.75B.
What was Gilead Sciences total liabilities in 2025?
- Gilead Sciences (GILD) total liabilities in 2025 was $36.41B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
GILD Overview
Company profile, financial tools, and key metrics
GILD Revenue Counter
Earns $933.60 every second. See per minute, hour, and day.
GILD Earnings Counter
Earns $269.85 per second net profit. See per minute, hour, and day.
GILD Economic Scale
Exceeds Albania's GDP. Compare with world economies.
GILD What If Invested
What if you had invested $1,000? See historical returns from any date.
GILD How It Makes Money
Discover visual breakdown of $29.44B in revenue — where it comes from and where it goes.
GILD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
GILD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
GILD Daily Price Character
Explosive · 48.7% historical win rate (green days). Streaks & record days.
GILD Buybacks
1.26% TTM buyback yield. Shareholder yield & SBC comparison.
GILD Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
GILD Dividend Profile
Yield: 2.48%. Safety: 8/8. See full history.
GILD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
GILD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.